SAN DIEGO--(BUSINESS WIRE)--May 9, 2018--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps available in the
United States, today announced that Kim Blickenstaff, president and CEO,
will present a company update at the Bank of America Merrill Lynch 2018
Healthcare Conference, which will be held at the Encore at the Wynn
Hotel in Las Vegas, Nevada. The presentation will take place on Tuesday,
May 15, 2018 at 12:35 PM Eastern Time (9:35 AM Pacific Time).
The presentation will be webcast live, and an archive recording will be
available for 30 days. The link to the live webcast and archive will be
accessible on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com
in the "Events & Presentations" section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. The Company takes an innovative, user-centric approach to
the design, development and commercialization of products for people
with diabetes who use insulin. Tandem manufactures and sells the t:slim
X2™ Insulin Pump, the only pump capable of remote feature updates using
a personal computer and the only available pump with Dexcom G5® Mobile
CGM integration. Tandem is based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2,
#tconnect, and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow
Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
Tandem Diabetes Care and t:slim X2 are registered trademarks. Dexcom G5
is a registered trademark of Dexcom, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180509006063/en/
Source: Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc.
Media Contact:
Steve
Sabicer, 714-907-6264
ssabicer@thesabicergroup.com
or
Investor
Contact:
Susan Morrison, 858-366-6900 x7005
ir@tandemdiabetes.com
